Delivery Order 36C24921D0004-36C24924N0064
- Not listed
- This is a delivery order awarded to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for the supply of reagents and stainers for the Department of Veterans Affairs (VA) over a performance period ending on September 30, 2025. The firm-fixed-price contract has a ceiling value of $480,738.00. Roche Diagnostics is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The company has held multiple...
- This is a delivery order awarded by the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation for the procurement of in vitro diagnostic reagents and supplies. The contract has a ceiling value of $230,482.66 and a period of performance through November 7, 2025. It is a firm-fixed-price contract with no set-aside designation. Roche Diagnostics is a leading manufacturer and distributor of medical diagnostic technologies, including laboratory instruments, reagents, and test kits. The...
- This is a $28,184.58 firm fixed price delivery order awarded by the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is for the delivery of reagents and has a period of performance through September 21, 2024. Roche Diagnostics has previously received multiple federal contract awards, including through the General Services Administration...
- This is a delivery order contract awarded by the Veterans Integrated Service Network 17 (VISN 17), a division of the U.S. Department of Veterans Affairs (VA), to Roche Diagnostics Corporation for reagents and consumables for the VENTANA medical diagnostic product line. The contract has a ceiling value of $392,455.91 and a period of performance through December 31, 2024. The contract is a firm-fixed-price delivery order, meaning Roche will provide the VA with a set quantity of reagents and...
- This is a delivery order contract awarded by the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a leading manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The contract, valued at $7,297.88, is for the provision of Roche reagents and supplies to the VA. The contract is not designated as a set-aside and is part of Roche's broader federal contracting portfolio, which includes several...
- This $222,918.10 firm fixed-price delivery order contract was awarded by the Veterans Integrated Service Network 10 of the Department of Veterans Affairs to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is for the provision of reagents and supplies, with a period of performance through January 31, 2026. Roche Diagnostics holds several indefinite delivery contracts and...
- This contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, to provide laboratory reagents. The contract is a Delivery Order valued at $194,961.65 and is not set aside. Roche Diagnostics is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. Through this and other prime federal contracts, Roche...
- This is a federal delivery order contract awarded by the Veterans Integrated Service Network 10 (VISN 10) of the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostic products. The $71,983.60 firm fixed-price contract is for the supply of Roche Diagnostic brand reagents and consumables supplies, with a period of performance through March 21, 2025. The contract has no set-aside designation. Roche Diagnostics has been awarded...
- This is a Delivery Order contract awarded by the Veterans Integrated Service Network 9 (VISN 9), a civilian agency within the Department of Veterans Affairs (VA), to Roche Diagnostics Corporation to provide Roche Reagents and Stainers. The order has a ceiling value of $382,991.63 and a completion date of September 30, 2023. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) held by Roche with the VA, which allows the agency to acquire laboratory instruments, reagents,...
- This $297,244.05 firm fixed price delivery order contract was awarded by the Veterans Integrated Service Network 6 (VISN 6) of the U.S. Department of Veterans Affairs to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, and laboratory equipment. The contract is for in vitro diagnostic reagents and supplies, and is not set-aside. Roche Diagnostics has previously held multiple General Services Administration (GSA) Schedule contracts and Indefinite...
- 36C24921D0004Indefinite Delivery Contract
- 36C24921D0004-36C24924N0064Delivery Order
This is a delivery order contract awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 9 to Roche Diagnostics Corporation, a leading manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The $426,632.84 firm-fixed-price contract is for the provision of Roche reagents and stainers, and does not have a set-aside designation. Roche Diagnostics Corporation holds multiple significant indefinite delivery vehicles (IDVs) and blanket purchase agreements (BPAs) across federal agencies, including a $37 million BPA with the Defense Health Agency and a $5.5 million BPA with VA's Veterans Integrated Service Network 10, primarily established under GSA Schedule contracts for critical analyzers, laboratory equipment, and in vitro diagnostics.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Supplemental Agreement for work within scope | ($54k) | 4/24/25 | |
| Not listed | Not listed | $480.7k | 10/1/23 |